Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Can-Fite Biopharma Ltd. > Hedge Fund Holdings

Can-Fite Biopharma Ltd. ()

Market is closed
Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Armistice Capital

Steven Boyd

 518,853 $1,338,641 +36% 0.01%
2.
Citadel Investment Group

Ken Griffin

 0 $0 0%
Insider Monkey Quarterly Strategy
+275.3% Insider Monkey Quarterly Strategy
+125.2% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through May 20, 2024)